437
Views
11
CrossRef citations to date
0
Altmetric
ENDOMETRIOSIS

Dioxin and endometriosis: a new possible relation based on epigenetic theory

, ORCID Icon, , , &
Pages 279-284 | Received 29 Mar 2019, Accepted 24 Nov 2019, Published online: 05 Dec 2019

References

  • Giampaolino P, Della Corte L, Saccone G, et al. Role of ovarian suspension in preventing postsurgical ovarian adhesions in patients with stage III–IV pelvic endometriosis: a systematic review. J Minim Invasive Gynecol. 2019;26(1):53–62.
  • Aznaurova YB, Zhumataev MB, Roberts TK, et al. Molecular aspects of development and regulation of endometriosis. Reprod Biol Endocrinol. 2014;12(1):50.
  • Kavoussi SK, Lim CS, Skinner BD, et al. New paradigms in the diagnosis and management of endometriosis. Curr Opin Obstet Gynecol. 2016;28(4):267–276.
  • Vercellini P, Viganò P, Somigliana E, et al. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261–275.
  • Giudice LC. Clinical practice. Endometriosis. N Engl J Med. 2010;362(25):2389–2398.
  • Viganò P, Parazzini F, Somigliana E, et al. Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol. 2004;18(2):177–200.
  • Moen MH, Magnus P. The familial risk of endometriosis. Acta Obstet Gynecol Scand. 1993;72(7):560–564.
  • Stefansson H, Geirsson RT, Steinthorsdottir V, et al. Genetic factors contribute to the risk of developing endometriosis. Hum Reprod. 2002;17(3):555–559.
  • Evers JL. Endometriosis does not exist; all women have endometriosis. Hum Reprod. 1994;9(12):2206–2209.
  • Nyholt DR, Low SK, Anderson CA, Painter JN, et al. Genome-wide association meta-analysis identifies new endometriosis risk loci. Nat Genet. 2012;44(12):1355–1359.
  • Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012;98(3):511–519.
  • Sofo V, Götte M, Laganà AS, et al. Correlation between dioxin and endometriosis: an epigenetic route to unravel the pathogenesis of the disease. Arch Gynecol Obstet. 2015;292(5):973–986.
  • Naqvi H, Ilagan Y, Krikun G, et al. Altered genome-wide methylation in endometriosis. Reprod Sci. 2014;21(10):1237–1243.
  • Holliday R. Epigenetics: a historical overview. Epigenetics. 2006;1(2):76–80.
  • Nasu K, Kawano Y, Tsukamoto Y, et al. Aberrant DNA methylation status of endometriosis: epigenetics as the pathogenesis, biomarker and therapeutic target. J Obstet Gynaecol Res. 2011;37(7):683–695.
  • Calicchio R, Doridot L, Miralles F, et al. DNA methylation, an epigenetic mode of gene expression regulation in reproductive science. CPD. 2014;20(11):1726–1750.
  • Wu Y, Halverson G, Basir Z, et al. Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis. Am J Obstet Gynecol. 2005;193(2):371–380.
  • Czyz W, Morahan JM, Ebers GC, et al. Genetic, environmental and stochastic factors in monozygotic twin discordance with a focus on epigenetic differences. BMC Med. 2012;10(1):93.
  • Cortessis VK, Thomas DC, Levine AJ, et al. Environmental epigenetics: prospects for studying epigenetic mediation of exposure-response relationships. Hum Genet. 2012;131(10):1565–1589.
  • Wu Y, Shi X, Guo SW. The knockdown of progesterone receptor isoform B (PR-B) promotes proliferation in immortalized endometrial stromal cells. Fertil Steril. 2008;90(4):1320–1323.
  • Koninckx PR, Ussia A, Adamyan L, et al. Pathogenesis of endometriosis: the genetic/epigenetic theory. Fertil Steril. 2019;111(2):327–340.
  • Knudson AG. Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad U S A. 1971;68(4):820–823.
  • Rier SE, Martin DC, Bowman RE, et al. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol. 1993;21(4):433–441.
  • Jacobson-Dickman E, Lee MM. The influence of endocrine disruptors on pubertal timing. Curr Opin Endocrinol Diabetes Obes. 2009;16(1):25–30.
  • De Jongh J, DeVito M, Nieboer R, et al. Induction of cytochrome P450 isoenzymes after toxicokinetic interactions between 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2,20,4,40,5,50-hexachlorobiphenyl in the liver of the mouse. Fundam Appl Toxicol. 1995;25(2):264–270.
  • Diliberto JJ, Akubue PI, Luebke RW, et al. Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)in mice. Toxicol Appl Pharmacol. 1995;130(2):197–208.
  • Guengerich FP. Metabolism of 17 alpha-ethynylestradiol in humans. Life Sci. 1990;47(22):1981–1988.
  • Zheng Y, Tabbaa ZM, Khan Z, et al. Epigenetic regulation of uterine biology by transcription factor KLF11 via posttranslational histone deacetylation of cytochrome p450 metabolic enzymes. Endocrinology. 2014;155(11):4507–4520.
  • Correa LF, Zheng Y, Delaney AA, et al. TGF-b induces endometriotic progression via a noncanonical, KLF11-mediated mechanism. Endocrinology. 2016;157(9):3332–3343.
  • Arisawa K, Takeda H, Mikasa H. Background exposure to PCDDs/PCDFs/PCBs and its potential health effects: a review of epidemiologic studies. J Med Invest. 2005;52(1,2):10–21.
  • Wormke M, Stoner M, Saville B, et al. Crosstalk between estrogen receptor alpha and the aryl hydrocarbon receptor in breast cancer cells involves unidirectional activation of proteasomes. FEBS Lett. 2000;478(1–2):109–112.
  • Beischlag TV, Perdew GH. ER alpha-AHR-ARNT protein-protein interactions mediate estradiol-dependent transrepression of dioxin-inducible gene transcription. J Biol Chem. 2005;280(22):21607–21611.
  • Ohtake F, Takeyama K, Matsumoto T, et al. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature. 2003;423(6939):545–550.
  • Birnbaum LS. The mechanism of dioxin toxicity: relationship to risk assessment. Environ Health Perspect. 1994;102(Suppl 9):157–167.
  • Tavakoly Sany SB, Hashim R, Salleh A, et al. Dioxin risk assessment: mechanisms of action and possible toxicity in human health. Environ Sci Pollut Res Int. 2015;22(24):19434–19450.
  • Van den Berg M, Birnbaum LS, Denison M, et al. The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci. 2006;93(2):223–241.
  • Uemura H, Arisawa K, Hiyoshi M, et al. PCDDs/PCDFs and dioxin-like PCBs: recent body burden levels and their determinants among general inhabitants in Japan. Chemosphere. 2008;73(1):30–37.
  • Schuhmacher M, Fàbrega F, Kumar V, et al. A PBPK model to estimate PCDD/F levels in adipose tissue: comparison with experimental values of residents near a hazardous waste incinerator. Environ Int. 2014;73:150–157.
  • U.S. EPA. Exposure and Human Health Reassessment of 2,3,7,8-Tetrachlorodibenzo-P-Dioxin (TCDD) and Related Compounds National Academy Sciences (External Review Draft) (EPA/600/P-00/001) (2004). Washington (DC): U.S. Environmental Protection Agency; 2004.
  • Muzembo BA, Iwai-Shimada M, Isobe T, et al. Dioxins levels in human blood after implementation of measures against dioxin exposure in Japan. Environ Health Prev Med. 2019;24(1):6.
  • Saito K, Takekuma M, Ogawa M, et al. Enzyme-linked immunosorbent assay toxicity evaluation method for dioxins in human milk. Bull Environ Contam Toxicol. 2003;70(4):636–643.
  • Sugawara Y, Saito K, Ogawa M, et al. Development of dioxin toxicity evaluation method in human milk by enzyme-linked immunosorbent assay––assay validation for human milk. Chemosphere. 2002;46(9–10):1471–1476.
  • Foster WG. Endocrine toxicants including 2,3,7,8-terachlorodibenzo-p-dioxin (TCDD) and dioxin-like chemicals and endometriosis: is there a link? J Toxicol Environ Health B Crit Rev. 2008;11(3–4):177–187.
  • Guo SW. The link between exposure to dioxin and endometriosis: a critical reappraisal of primate data. Gynecol Obstet Invest. 2004;57(3):157–173.
  • Martínez-Zamora MA, Mattioli L, Parera J, et al. Increased levels of dioxin-like substances in adipose tissue in patients with deep infiltrating endometriosis. Hum Reprod. 2015; May;30(5):1059–1068.
  • Smarr MM, Kannan K, Buck Louis GM. Endocrine disrupting chemicals and endometriosis. Fertil Steril. 2016;106(4):959–966.
  • Kohlmeier L, Kohlmeier M. Adipose tissue as a medium for epidemiologic exposure assessment. Environ Health Perspect. 1995;103(Suppl 3):99–106.
  • Ploteau S, Cano-Sancho G, Volteau C, et al. Associations between internal exposure levels of persistent organic pollutants in adipose tissue and deep infiltrating endometriosis with or without concurrent ovarian endometrioma. Environ Int. 2017;108:195–203.
  • Guo SW, Simsa P, Kyama CM, et al. Reassessing the evidence for the link between dioxin and endometriosis: from molecular biology to clinical epidemiology. Mol Hum Reprod. 2009;15(10):609–624.
  • Patrizi B, Siciliani de Cumis M. TCDD Toxicity mediated by epigenetic mechanisms. Int J Mol Sci. 2018;19(12):4101.
  • Baccarelli A, Bollati V. Epigenetics and environmental chemicals. Curr Opin Pediatr. 2009;21(2):243–251.
  • Tang WY, Ho SM. Epigenetic reprogramming and imprinting in origins of disease. Rev Endocr Metab Disord. 2007;8(2):173–182.
  • Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet. 2007;8(4):253–262.
  • Skinner MK, Manikkam M, Guerrero-Bosagna C. Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol Metab. 2010;21(4):214–222.
  • Yan W. Potential roles of noncoding RNAs in environmental epigenetic transgenerational inheritance. Mol. Cell. Endocrinol. 2014;398(1–2):24–30.
  • Beedanagari SR, Taylor RT, Bui P, Wang F, et al. Role of epigenetic mechanisms in differential regulation of the dioxin-inducible human CYP1A1 and CYP1B1 genes. Mol Pharmacol. 2010;78(4):608–616.
  • Martin EM, Fry RC. Environmental influences on the epigenome: exposure- associated DNA methylation in human populations. Annu Rev Public Health. 2018;39(1):309–333.
  • Grimstad FW, Decherney A. A review of the epigenetic contributions to endometriosis. Clin Obstet Gynecol. 2017;60(3):467–476.
  • Singh NP, Singh UP, Singh B, et al. Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis. PLoS One. 2011;6(8):e23522.
  • Wu Q, Ohsako S, Ishimura R, et al. Exposure of mouse preimplantation embryos to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters the methylation status of imprinted genes H19 and Igf2. Biol Reprod. 2004;70(6):1790–1797.
  • Wang C, Yuan XG, Liu CP, et al. Preliminary research on DNA methylation changes during murine palatogenesis induced by TCDD. J Craniomaxillofac Surg. 2017;45(5):678–684.
  • Aluru N, Kuo E, Helfrich LW, et al. Developmental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin alters DNA methyltransferase (dnmt) expression in zebrafish (Danio rerio). Toxicol Appl Pharmacol. 2015;284(2):142–151.
  • Amenya HZ, Tohyama C, Ohsako S. Dioxin induces Ahr-dependent robust DNA demethylation of the Cyp1a1 promoter via Tdg in the mouse liver. Sci Rep. 2016;6(1):34989.
  • Koike N, Higashiura Y, Akasaka J, et al. Epigenetic dysregulation of endometriosis susceptibility genes (Review). Mol Med Rep. 2015;12(2):1611–1616.
  • Teague EM, Print CG, Hull ML. The role of micro- RNAs in endometriosis and associated reproductive conditions. Hum Reprod Update. 2010;16:142–165.
  • Nothnick WB, Al-Hendy A, Lue JR. Circulating micro-RNAs as diagnostic biomarkers for endometriosis: privation and promise. J Minim Invasive Gynecol. 2015;22(5):719–726.
  • Hull ML, Nisenblat V. Tissue and circulating microRNA influence reproductive function in endometrial disease. Reprod Biomed Online. 2013;27:515–529.
  • Han SJ, O’Malley BW. The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis. Hum Reprod Update. 2014;20(4):467–484.
  • Khan Z, Zheng Y, Jones TL, et al. Epigenetic therapy: novel translational implications for arrest of environmental dioxin-induced disease in females. Endocrinology. 2018;159(1):477–489.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.